<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url>
    <loc>https://priyalifescience.com/article/obesity-power-rankings-who-will-challenge-lilly-novo</loc>
    <lastmod>2026-06-25T10:16:30+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T10:16:30+00:00</news:publication_date>
      <news:title>The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?</news:title>
      <news:keywords>Industry News, obesity power rankings who will challenge lilly novo, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/obesity_rankings_pro.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/viewpoint-ireland-pharma-immune-carbon-leakage</loc>
    <lastmod>2026-06-25T10:16:29+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T10:16:29+00:00</news:publication_date>
      <news:title>Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus</news:title>
      <news:keywords>Industry News, viewpoint ireland pharma immune carbon leakage, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/ireland_pharma_climate.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/helus-pharma-50-million-offering</loc>
    <lastmod>2026-06-25T10:16:29+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T10:16:29+00:00</news:publication_date>
      <news:title>Helus Pharma Secures US$50M Offering as MDD Trial Surpasses 86% Enrollment</news:title>
      <news:keywords>Industry News, helus pharma 50 million offering, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/helus_pharma_offering.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/nice-recommends-libtayo-advanced-cervical-cancer</loc>
    <lastmod>2026-06-25T10:16:29+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T10:16:29+00:00</news:publication_date>
      <news:title>NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales</news:title>
      <news:keywords>Industry News, nice recommends libtayo advanced cervical cancer, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/libtayo_nice_approval.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/iua-strategy-2026-2030-launch</loc>
    <lastmod>2026-06-25T10:16:29+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T10:16:29+00:00</news:publication_date>
      <news:title>Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts</news:title>
      <news:keywords>Industry News, iua strategy 2026 2030 launch, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/iua_strategy_2026.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/overcome-middle-management-resistance-ai-ireland-pharma</loc>
    <lastmod>2026-06-25T08:01:40+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T08:01:40+00:00</news:publication_date>
      <news:title>Leading Digital Transformation in Ireland’s Pharma Sector: 5 Ways to Overcome Middle Management Resistance to AI</news:title>
      <news:keywords>AI &amp; Digital Innovation, overcome middle management resistance ai ireland pharma, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/pharma_ai_poster.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/how-to-overcome-middle-management-resistance-ai-ireland-pharma</loc>
    <lastmod>2026-06-25T06:31:51+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-25T06:31:51+00:00</news:publication_date>
      <news:title>How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions</news:title>
      <news:keywords>AI &amp; Digital Innovation, how to overcome middle management resistance ai ireland pharma, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/ireland_pharma_ai.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/workequal-ireland-empowering-women-workplace-equality</loc>
    <lastmod>2026-06-23T18:53:48+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-23T18:53:48+00:00</news:publication_date>
      <news:title>Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland</news:title>
      <news:keywords>Life Sciences Ireland, workequal ireland empowering women workplace equality, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/workequal_presentation.jpg</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/pharma-ma-surge-h1-2026-biotech-acquisitions</loc>
    <lastmod>2026-06-23T18:34:50+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-23T18:34:50+00:00</news:publication_date>
      <news:title>A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&amp;A Surge</news:title>
      <news:keywords>Industry News, pharma ma surge h1 2026 biotech acquisitions, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/pharma_ma_surge_2026.png</image:loc></image:image>
  </url>
<url>
    <loc>https://priyalifescience.com/article/europe-medicine-pricing-warning-investment-risk</loc>
    <lastmod>2026-06-23T18:34:50+00:00</lastmod>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-23T18:34:50+00:00</news:publication_date>
      <news:title>The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments</news:title>
      <news:keywords>Industry News, europe medicine pricing warning investment risk, pharma Ireland, life science Ireland, pharmaceutical news Ireland, biopharma Europe, EMA, HPRA, biotech Ireland, MedTech Ireland</news:keywords>
    </news:news>
    <image:image><image:loc>https://priyalifescience.com/assets/images/europe_medicine_pricing_warning.png</image:loc></image:image>
  </url>
</urlset>